Once-weekly glucagon-like peptide receptor agonist polyethylene glycol loxenatide protects against major adverse cardiovascular events in patients with type 2 diabetes: a multicenter ambispective cohort study (FLYING trial)
每周一次的胰高血糖素样肽受体激动剂聚乙二醇洛塞那肽可预防 2 型糖尿病患者发生重大不良心血管事件:一项多中心前瞻性队列研究(FLYING 试验)
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70094
Li, Jilin; Tian, Yu; Li, Liping; Zhao, Yanyan; Yang, Shuhui; Xu, Wencan; Zhu, Dan; Ye, Junjun; Chen, Jingxian; Liu, Weiting; Xue, Haibo; Wu, Wei; Deng, Feiying; Duan, Yale; Hu, Zhizhen; Xie, Bin; Chen, Zhe-Sheng; Hou, Kaijian